Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | EVP, Pharmaceutical Operations | February 17, 2004 | February 19, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date February 17, 2004 · Filed February 19, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.11 · Expires 2014-02-14 | Direct | 120,000 |
Reported balance
After 2004-02-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2004-02-17 · Grant · Acquired 120,000 · Balance 120,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2004 Filed Feb 19, 2004 19:02 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantEmployee stock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $73.11 | $0.00 |
DisclosureSEC source: 0000059478-04-000065 · doc4.xml · derivative · entry 1 MAYR GERHARD N · CIK 0001233255 · EVP, Pharmaceutical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2014-02-14 Read SEC document |
| February 02, 2004 Filed Feb 17, 2004 21:14 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantEmployee stock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $68.72 | $0.00 |
DisclosureSEC source: 0000059478-04-000041 · doc4.xml · derivative · entry 1 MAYR GERHARD N · CIK 0001233255 · EVP, Pharmaceutical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2014-01-31 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.